Laily UPN

A Fractured Partnership: The WHO Responds to the U.S. Withdrawal $a-fractured-partnership-the-who-responds-to-the-u-s-withdrawal$

A Fractured Partnership: The WHO Responds to the U.S. Withdrawal

Laily UPN October 24, 2026

Introduction: A Historical Schism in Global Health The relationship between the United States and the World Health...

Navigating the Orphan Frontier: The FDA’s Ambitious New "Rare Disease Framework Initiative" navigating-the-orphan-frontier-the-fdas-ambitious-new-rare-disease-framework-initiative-4

Navigating the Orphan Frontier: The FDA’s Ambitious New "Rare Disease Framework Initiative"

Laily UPN October 24, 2026

In a significant move aimed at streamlining the often-labyrinthine path to drug approval, the U.S. Food and...

A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Mitochondrial Donation a-new-dawn-for-reproductive-medicine-eight-healthy-infants-born-via-mitochondrial-donation-2

A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Mitochondrial Donation

Laily UPN October 24, 2026

In a landmark achievement for reproductive medicine and genomic science, researchers at Newcastle University and The Newcastle...

Beyond the Monolith: Why Ultra-Processed Food Labels May Mask Nuanced Health Risks beyond-the-monolith-why-ultra-processed-food-labels-may-mask-nuanced-health-risks

Beyond the Monolith: Why Ultra-Processed Food Labels May Mask Nuanced Health Risks

Laily UPN October 24, 2026

For decades, the dietary landscape of the United States has been dominated by ultra-processed foods (UPFs). These...

Roche Deepens Strategic Ties with Hansoh Pharma in Landmark $400 Million ADC Collaboration roche-deepens-strategic-ties-with-hansoh-pharma-in-landmark-400-million-adc-collaboration

Roche Deepens Strategic Ties with Hansoh Pharma in Landmark $400 Million ADC Collaboration

Laily UPN October 23, 2026

Executive Summary: A New Paradigm in Oncology R&D In a move that underscores the shifting landscape of...

The mRNA Frontier: Moderna and Merck’s Cancer Vaccine Hits Landmark Milestone in Melanoma Fight the-mrna-frontier-moderna-and-mercks-cancer-vaccine-hits-landmark-milestone-in-melanoma-fight

The mRNA Frontier: Moderna and Merck’s Cancer Vaccine Hits Landmark Milestone in Melanoma Fight

Laily UPN October 22, 2026

In the high-stakes world of oncology, the quest for a therapeutic cancer vaccine has long been considered...

A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Pioneering Mitochondrial Donation a-new-dawn-for-reproductive-medicine-eight-healthy-infants-born-via-pioneering-mitochondrial-donation-7

A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Pioneering Mitochondrial Donation

Laily UPN October 21, 2026

In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...

Bridging the Data Divide: How the WHO’s ‘SCORE’ Initiative is Revolutionizing Global Health Intelligence bridging-the-data-divide-how-the-whos-score-initiative-is-revolutionizing-global-health-intelligence

Bridging the Data Divide: How the WHO’s ‘SCORE’ Initiative is Revolutionizing Global Health Intelligence

Laily UPN October 21, 2026

In the wake of the COVID-19 pandemic—a crisis that laid bare the fragile state of global health...

Duvakitug Emerges as a Potential Differentiator in the Heated Race for Inflammatory Bowel Disease Therapies duvakitug-emerges-as-a-potential-differentiator-in-the-heated-race-for-inflammatory-bowel-disease-therapies

Duvakitug Emerges as a Potential Differentiator in the Heated Race for Inflammatory Bowel Disease Therapies

Laily UPN October 21, 2026

Sanofi and Teva Pharmaceuticals’ investigational anti-TL1A therapy, duvakitug, has demonstrated significant promise in treating both ulcerative colitis...

Navigating the Geopolitical Fault Lines: The WHO and the U.S. Withdrawal Crisis navigating-the-geopolitical-fault-lines-the-who-and-the-u-s-withdrawal-crisis-2

Navigating the Geopolitical Fault Lines: The WHO and the U.S. Withdrawal Crisis

Laily UPN October 21, 2026

The international health landscape faces a period of profound uncertainty as the World Health Organization (WHO) navigates...

A Fractured Partnership: The WHO Responds to the U.S. Withdrawal

Navigating the Orphan Frontier: The FDA’s Ambitious New "Rare Disease Framework Initiative"

A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Mitochondrial Donation

Beyond the Monolith: Why Ultra-Processed Food Labels May Mask Nuanced Health Risks

Roche Deepens Strategic Ties with Hansoh Pharma in Landmark $400 Million ADC Collaboration

The mRNA Frontier: Moderna and Merck’s Cancer Vaccine Hits Landmark Milestone in Melanoma Fight

A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Pioneering Mitochondrial Donation

Bridging the Data Divide: How the WHO’s ‘SCORE’ Initiative is Revolutionizing Global Health Intelligence

Duvakitug Emerges as a Potential Differentiator in the Heated Race for Inflammatory Bowel Disease Therapies

Navigating the Geopolitical Fault Lines: The WHO and the U.S. Withdrawal Crisis

You may have missed

Unveiling a Cancer’s Deceptive Alliance: OU Research Exposes How Breast Tumors Recruit Nerves to Fuel Growth

Influenza mortality in hospitalised patients affected by vaccination

Beyond the Pink: Demanding Transparency and Tangible Impact in Breast Cancer Awareness Month Campaigns

The Stage IV Stampede: Metastatic Breast Cancer Advocates Descend on Capitol Hill to Demand Legislative Reform